BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29118054)

  • 1. Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England.
    Earl KE; Sakellariou GK; Sinclair M; Fenech M; Croden F; Owens DJ; Tang J; Miller A; Lawton C; Dye L; Close GL; Fraser WD; McArdle A; Beadsworth MBJ
    BMJ Open; 2017 Nov; 7(11):e015296. PubMed ID: 29118054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
    Domingo JC; Battistini F; Cordobilla B; Zaragozá MC; Sanmartin-Sentañes R; Alegre-Martin J; Cambras T; Castro-Marrero J
    J Transl Med; 2024 Apr; 22(1):343. PubMed ID: 38600563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ; Sunnquist M; Jason LA; Newton JL
    BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.
    Lacerda EM; McDermott C; Kingdon CC; Butterworth J; Cliff JM; Nacul L
    Health Expect; 2019 Jun; 22(3):373-384. PubMed ID: 30632248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study.
    Castro-Marrero J; Faro M; Aliste L; Sáez-Francàs N; Calvo N; Martínez-Martínez A; de Sevilla TF; Alegre J
    Psychosomatics; 2017; 58(5):533-543. PubMed ID: 28596045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care.
    Nacul LC; Lacerda EM; Pheby D; Campion P; Molokhia M; Fayyaz S; Leite JC; Poland F; Howe A; Drachler ML
    BMC Med; 2011 Jul; 9():91. PubMed ID: 21794183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study.
    Słomko J; Newton JL; Kujawski S; Tafil-Klawe M; Klawe J; Staines D; Marshall-Gradisnik S; Zalewski P
    BMJ Open; 2019 Mar; 9(3):e023955. PubMed ID: 30850404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis.
    Escorihuela RM; Capdevila L; Castro JR; Zaragozà MC; Maurel S; Alegre J; Castro-Marrero J
    J Transl Med; 2020 Jan; 18(1):4. PubMed ID: 31906988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
    Huth TK; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 May; 18(1):198. PubMed ID: 32404171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
    Cash A; Kaufman DL
    J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME.
    Daniels J; Brigden A; Kacorova A
    Psychol Psychother; 2017 Sep; 90(3):502-509. PubMed ID: 28244209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study.
    Harvey SB; Wadsworth M; Wessely S; Hotopf M
    Psychol Med; 2008 Jul; 38(7):933-40. PubMed ID: 17976252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.
    Devereux-Cooke A; Leary S; McGrath SJ; Northwood E; Redshaw A; Shepherd C; Stacey P; Tripp C; Wilson J; Mar M; Boobyer D; Bromiley S; Chowdhury S; Dransfield C; Almas M; Almelid Ø; Buchanan D; Garcia D; Ireland J; Kerr SM; Lewis I; McDowall E; Migdal M; Murray P; Perry D; Ponting CP; Vitart V; Wolfe JC
    BMC Neurol; 2022 Jul; 22(1):269. PubMed ID: 35854226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.